Breakthroughs in Chronic Lymphocytic Leukemia from ASH 2011
Dr. Steven Rosen, director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, shares his perspective about the latest chronic lymphocytic leukemia (CLL) news from the American Society of Hematology's 2011 annual meeting. Dr. Rosen explores CLL breakthroughs, including a new, non-chemotherapy treatment that may provide a better tolerated approach to treating the disease, especially for older patients and those with genetic variations that do not respond to the current standard of care.
Experts & Guests
Steven T. Rosen, M.D.
Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial HospitalDr. Steven Rosen is the Genevieve Teuton Professor of Medicine and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He received his medical degree from the Northwestern University Feinberg School of Medicine and completed his residency training at McGaw Medical Center of Northwestern University. Dr. Rosen is board certified in hematology, internal medicine and medical oncology. more >